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Bhallataka Phala (fruit of Semecarpus anacardium L.), is a well-known anti-hyperlipidaemic drug. Bhallataka is 
described in all Ayurvedic classics as Rasayana and advocated for various therapeutic purposes such as Kushtha (skin 
diseases), Arsha (piles), Krimi (worm infestations), Prameha (urine disorders), Medodosha (lipid disorders), etc. Though its 
anti-hyperlipidaemic activity has been studied; actual differentiation in their therapeutic efficacy due to storage period has 
yet not been attempted on experimental animals. This prompted to initiate a comparative anti-hyperlipidemic activity of 
fixed oil (expressed oil) i.e. non-volatile in nature collected from fresh Bhallataka and four months old (cured) Bhallataka 
samples against cholesterol diet induced hyperlipidaemia in rats. Hyperlipidemia was induced by oral administration of 
cholesterol (20 % suspension in coconut oil, 5 mL/kg) in morning hours and hydrogenated vegetable oil (5 mL/kg) in 
evening. The effect of drugs was assessed on body weight, serum biochemical and histological parameters. Both drugs 
produced significant attenuation of the relative weight of liver in cholesterol-fed animals. Cured sample of Bhallataka 
provided better effect in lowering serum cholesterol (21.98 %), triglyceride (60.23 %), VLDL (56.82 %); while fresh sample 
of Bhallataka also found to be effective in lowering serum cholesterol (20.69 %), serum triglyceride (45.59 %), VLDL 
(46.59 %) in comparison to control group. From the result of the present study, it is concluded that the cured sample of 
Bhallataka has pronounced anti-hyperlipidemic effect than the fresh sample in experimentally-induced hyperlipidemia in rats. 
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Introduction 
Hyperlipidaemia involves abnormally elevated 
levels of any one of total cholesterol, low-density 
lipoprotein, triglycerides or all lipids in the serum 
blood plasma. The metabolic consequences associated 
with changes in diet and lifestyle has increased the 
number of hyperlipidemic individuals who could 
benefit from lipid-lowering therapy1. Lipoproteins 
play an essential role in the absorption of dietary 
cholesterol, long chain fatty acids and fat-soluble 
vitamins so help in transport of triglycerides, 
cholesterol and fat-soluble vitamins from the liver to 
peripheral tissues and vice versa. Multiple 
epidemiologic studies have demonstrated a strong 
relationship between serum cholesterol, elevated 
plasma triglyceride levels and coronary heart disease 
(CHD). Cardiovascular diseases are the number one 
cause of death globally2. An estimated 7.3 million 
death were due to coronary heart disease and 6.2 
million were due to stroke3. The traditional system of 
medicines is a better alternative with minimal side 
effects to combat these types of disorders. 
Bhallataka (Semecarpus anacardium L.) belonging 
to family Anacardiaceae is a common tree found 
throughout the country especially in the Himalayas and 
hotter parts of Indian in dry and moist deciduous 
forests4. The fruit is useful in treating many diseases 
like Kushtha (skin diseases), Arsha (piles), Krimi 
(worm infestations), Prameha (urine disorders), 
Medodosha (lipid disorders) etc5 and is emphasized as 
best Rasayana (rejuvenator). Fruit of S. anacardium is 
well known for its anti-hyperlipidaemic property 
(Medodoshanashaka)6. Kala-Prakarsha Samskara 
(curing) is one of the important Samskara (processing 
and propagation) especially mentioned in Ayurvedic 
texts, which plays a major role in propagating the 
therapeutic efficacy and safety of medicines7. Kala 
Prakarsha Samskara especially emphasizes for 
Bhallataka i.e. storage of Bhallataka fruits in heap of 
barley for a period of four months in rainy season8. 
Preservation time alters the drug properties, mainly its 
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potency. Several pharmacological and clinical trials are 
reported pertaining to Bhallataka fruit9-11 but 
experimental studies for comparing the efficacy of 
fresh and cured samples have not yet been found. 
Therefore, the present study was planned with an aim 
to evaluate the comparative anti-hyperlipidaemic 
efficacy of fresh and cured Bhallataka fruits in  
albino rats. 
 
Materials and Methods 
 
Drug 
Fresh Bhallataka fruits were collected from Jalna 
(19.83o N 75.88o E) Maharashtra, India during 
Shucho-Shukre (the month of April and May 2013)12. 
The drug was identified and authenticated at 
Pharmacognosy Laboratory, Institute for Post 
Graduate Teaching and Resarch in Ayurveda, Gujarat 
Ayurved University, Jamnagar and voucher specimen 
was deposited (IPGT&RA/Phm/6165). Prashasta 
(acceptable) and Aprashasta (unacceptable) qualities 
of fruits were analyzed by immersing them in a vessel 
containing potable water in a glass jar. The fruits that 
settled down were collected carefully and used for 
further experimental study while the floated fruits 
were discarded as they are unacceptable for the study. 
 
Curing of Bhallataka 
Acceptable fruits were kept in an aluminium box of 
50×35.5×55 cm (L×B×H) filled with a heap of barley 
to maintain constant temperature and humidity for 
four months. Before filling barley inside the box, 
thermocol sheets of 10 mm width were taken and cut 
off with proper dimension, now these sheets were 
wrapped with aluminium foil of thickness of  
0.009-0.03 mm and width of 250 mm and pasted to 
the walls of the box. Another cabin was prepared 
from plain thermocol sheets inside the box with  
4.5 cm distanced from previously fitted aluminium 
foil. Yava (Barley - Hordeum vulgare) fruits were 
filled in the created 4.5 cm space in between and 
lower down the previous sheets. Now, the batches of 
Bhallataka were arranged in the box with alternative 
barley layers. Finally, barley fruits layers were 
arranged on the upper part and box were closed for 
four months. After four months, fruits were collected 
and processed for further use. 
 
Bhallataka oil extraction  
Both samples of Bhallataka fruits were subjected 
to oil extraction by Patala yantra (Pit Method)13. 
Bhallataka fruits were taken inside the vessel after 
cutting off its pseudocarp and then the mouth of the 
vessel was wrapped with mesh and another small 
vessel was fitted upon this large vessel. The whole 
arrangement was wrapped with mud smeared cloth and 
then put in a pit. Now, covered with cow-dung cakes 
and light was ignited. By this process, oil from fruits 
was extracted and collected into the small vessel. 
 
Bhallataka Kshaudra formation process 
To 20 g of Madhu (Honey), 160 g oil was added, 
then, 320 g Ghrita (cow ghee) was mixed and triturated 
for the homogeneous mixture as per Ayurvedic classic14. 
The same procedure was followed for the preparation of 
both test formulations i.e. fresh (FB) and cured (CB) 
samples of Bhallataka Kshaudra. 
 
Animals 
Wistar strain albino rats of either sex, weighing 
200±20 g were used for the experiment. The animals 
were maintained under standard conditions of 
temperature (22±02 °C), humidity (50-60 %) and 
exposed to 12 hour light and dark cycles. All animals 
were exposed to the same environmental conditions 
and were maintained on a standard diet and water ad 
libitum. The experimental protocol was approved by 
the Institutional Animal Ethical Committee 
(M.D./IAEC/14/2013/18) as per guidelines of 
CPCSEA, India.  
 
Dose  
The human dose of Bhallataka Kshaudra is 
considered as 500 mg/day15. Rat dose was calculated 
on basis of body surface area ratio by referring to the 
table of Paget and Barnes (1964)16. Based on that, the 
rat dose was fixed at 45 mg/kg. The test drug 
formulations were administered through the oral route 
by licking.  
 
Experimental design 
Protocol designed in the earlier study was followed 
in the present study with modifications as per 
experimental need17. Wistar albino rats of either sex 
were divided into five groups of six animals each. 
Group (I) was kept as normal control (NC) which 
received distilled water (10 mL/kg, po). Group (II) of 
animals kept as cholesterol control group, received 
distilled water (10 mL/kg, po) and hyperlipidaemic 
diet. Group (III) of animals were treated with 
atorvastatin (7.2 mg/kg, po) along with 
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hyperlipidaemic diet (SC). Group (IV) and (V) were 
kept as drug-treated groups which received fresh 
Bhallataka Kshaudra (FB) (45 mg/kg) and cured 
Bhallataka Kshaudra (CB) (45 mg/kg) orally along 
with hyperlipidemic diet. 
Test formulations and vehicle were administered to 
respective groups in the morning hours daily for 21 
days. The hyperlipidaemic diet was concomitantly 
administered to Group (II) to (V) to induce 
hyperlipidemia. The hyperlipidemic diet included 
cholesterol suspension in coconut oil and 
hydrogenated vegetable oil. Cholesterol extra pure 
powder (SRL, Mumbai) made into 20 % suspension 
in coconut oil and administered orally (5 mL/kg) in 
the morning hours after 1 hour of drug administration 
while, hydrogenated vegetable oil (5 mL/kg) (Adani 
Wilmar Ltd., Gujarat) was administered in  
evening hours. 
On the 22nd day, the overnight fasted rats were 
weighed again and blood was collected from retro-
orbital puncture under light ether anaesthesia using 
capillary tubes, serum was separated and used for 
estimation of different serum biochemical parameters. 
An autoanalyzer (BS 200) was used for the 
estimations of serum total cholesterol18, triglyceride19, 
VLDL-cholesterol, Urea20, creatinine21, blood sugar22, 
total protein23, albumin, globulin24, SGOT25, SGPT26 
and alkaline phosphatase27. The rats were sacrificed 
and important organs like the liver, kidney, heart and 
aorta were excised out. The extraneous tissues were 
cleaned off and weight of organs was noted down 
except for aorta and stored in 10 % formalin solution 
for histopathological study28. 
 
Statistical analysis 
The data is expressed as meanstandard error of mean 
for six rats per experimental group. Student’s t-test was 
used to compare the unpaired data to determine the 
significant difference between groups at p <0.05. 
Results 
Cholesterol control, standard drug, and cured 
Bhallataka groups showed almost similar values of 
body weight gain during the experimental period while 
fresh Bhallataka treated group showed a decrease in 
body weight in comparison to initial values (Table 1). 
Cholesterol control group showed a non-significant 
increase in relative weight of liver while significant 
decrease (p <0.05) in the relative weight of kidney in 
comparison to normal control group (Table 1). Test 
drugs produced a non-significant decrease in relative 
weight of heart, liver and kidney except for a 
significant decrease in relative weight of kidney in 
cured Bhallataka treated group. 
Cholesterol-fed rats showed statistically significant 
increase in total cholesterol (p <0.05), triglyceride (p 
<0.001), VLDL-cholesterol (p <0.05) and blood urea 
(p <0.001) level in comparison to normal control rats. 
Standard drug and both the fresh and cured 
Bhallataka Kshaudra showed a statistically 
significant decrease in cholesterol (p <0.05), 
triglyceride (p <0.001) and VLDL-cholesterol (p 
<0.001) level in comparison to cholesterol control 
group. Cured Bhallataka Kshaudra produced better 
effects on lipid profile and blood urea followed by 
fresh Bhallataka Kshaudra (Table 2).  
Cured Bhallataka Kshaudra showed a statistically 
significant decrease while fresh Bhallataka Kshaudra 
produced a non-significant decrease in blood glucose 
level as compared to cholesterol control group 
whereas both the test drugs showed a significant 
decrease in total protein, albumin and creatinine (p 
<0.05) level in comparison to cholesterol control 
group (Table 2). Cholesterol-fed rats showed a 
significant increase in SGOT, alkaline phosphatase (p 
<0.001) and bilirubin (p <0.05) level in comparison to 
the normal control group. Both the test drugs and 
atorvastatin-treated groups showed a statistically 
significant decrease in SGOT level, total and direct 
Table 1 — Effect of test drugs on body weight and relative organ weight of albino rats during anti-hyperlipidaemic study 
Groups Body weight Relative weight (g/100 g body weight) 
Initial (g) Final (g) Liver Heart Kidney 
NC 177.33±5.90 188.00±4.68 3.377±0.186 0.316±0.017 0.763±0.020 
CC 212.00±5.42 222.00±12.22 3.583±0.0804 0.317±0.010 0.713±0.004# 
SC 179.67±1.75 189.33±3.17 3.492±0.207 0.328±0.005 0.694±0.029 
FB 214.67±7.60 208.33±5.20 3.466±0.103 0.298±0.007 0.677±0.018 
CB 206.67±12.56 224.00±12.04 3.481±0.130 0.310±0.010 0.650±0.004** 
Data: Mean±SEM, #p <0.05 when compared to normal control group; ** p <0.001 when compared to cholesterol control group, 
NC– Normal Control, CC– Cholesterol control, SC– Standard control, FB– Fresh Bhallataka Kshaudra, CB– Cured Bhallataka Kshaudra 
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bilirubin levels while a non-significant decrease in 
alkaline phosphatase level in comparison to 
cholesterol control group (Table 3). 
Histopathological studies have shown that, control 
group exhibits normal cytoarchitecture in aorta, heart, 
kidney and liver (Fig. 1a, 2a, 3a and 4a) respectively. 
Cholesterol administration in rats produced mild 
increase in thickness of adventitia of aorta (Fig. 1b, c), 
moderate fatty degenerative changes in heart (Fig. 2b, c), 
fatty degeneration, edematous changes and intense cell 
infiltration in kidney (Fig. 3b, c) and liver (Fig. 4b, c). 
Sections from fresh and cured Bhallataka Kshaudra 
treated groups showed normal cytoarchitecture of aorta 
(Fig. 1d, e), mild fatty changes in heart (Fig. 2d, e), mild  
fatty changes with edema in kidney (Fig. 3d, e) and mild 
fatty changes in liver (Fig. 4d, e) in comparison to 
cholesterol control group. Standard drug treated rats 
showed normal cytoarchitecture of aorta (Fig. 1f), 
moderate fatty degenerative changes and necrosis in 
heart (Fig. 2f), normal cytoarchitecture of kidney  
(Fig. 3f) and mild fatty changes in liver (Fig. 4f). 
 
Discussion  
Bhallataka is mentioned as Medonashaka in 
Ayurvedic text6. The previous study also suggests the 
anti-hyperlipidaemic effect of an extract of 
Bhallataka29 but, the difference in the fresh and cured 
fruits of Bhallataka prepared as per the classical 
method is not yet reported. The present study is carried 
out to evaluate the comparative anti-hyperlipidaemic 
efficacy of fresh and cured Bhallataka fruits in albino 
rats. Administration of hyperlipidaemia diet led to a 
marked increase in body weight, CB showed an 
increase in body weight but on the other hand, FB 
showed a decrease in body weight compared to initial 
values but the effect was non-significant. Cholesterol 
control group showed a non-significant increase in 
relative weight of liver and heart in comparison to 
control group whereas, drug-treated groups showed a 
non-significant decrease in relative weight of liver and 
heart in comparison to cholesterol control group. The 
weight of kidney significantly decreased in the 
cholesterol control group in comparison to control 
group. CB treated group showed significant decrease 
whereas, non-significant decrease in rest of the groups 
in comparison to cholesterol control group. 
Administration of cholesterol and hyperlipidemic 
diet lead to significant elevation of serum total 
cholesterol, triglycerides, and VLDL-cholesterol 
Table 2 — Effect of test drugs on lipid profile, urea content, blood sugar, total protein, albumin and globulin level in albino rats during 
anti-hyperlipidaemic study 
Parameters  Groups 
NC CC SC FB CB 
Cholesterol (mg/ dL) 46.00±3.22 77.33±6.36# 56.50±2.63* 61.33±2.93* 60.33±3.461* 
Triglyceride (mg/ dL) 96.50±14.05 176.00±9.59# 104.67±11.82** 94.00±5.42** 70.00±10.16** 
VLDL (mg/ dL) 19.30±2.81 35.20±1.92# 20.93±2.36** 18.80±1.08** 15.20±1.97** 
Urea (mg/dL) 43.50±1.48 61.50±1.65# 41.00±3.20** 41.67±1.26** 34.17±1.17** 
Total protein (mg/ dL) 7.28 ±0.16 7.75±0.145 7.62±0.162 6.80±0.115** 6.85±0.118** 
Albumin (mg/ dL) 3.88±0.083 3.75±0.062 4.05±0.085* 3.50±0.089* 3.32±0.087* 
Globulin (mg/ dL) 3.40±0.13 4.05±0.178# 3.60±0.255 3.30±0.0775* 3.533±0.193 
Creatinine (mg/ dL) 0.55 ±0.02 0.55±0.02 0.53±0.03 0.42±0.05* 0.43±0.04* 
Sugar (mg/dL) 103.83±5.78 96.00±8.32 96.67±5.03 76.17±4.06 72.83±2.96* 
Data: Mean±SEM, # p <0.05, # p <0.001 when compared to normal control group; * p <0.05, ** p <0.001 when compared to cholesterol 
control group 
 
Table 3 — Effect of test drugs on SGOT, SGPT alkaline phosphatase and creatinine level in albino rats during anti-hyperlipidaemic study
Groups SGPT (IU/L) SGOT (IU/L) ALP (IU/L) Bilirubin 
(T) (mg/dL) 
Bilirubin (D) 
(mg/ dL) 
NC 53.00±2.86 145.17±6.48 269.00±46.83 0.65±0.10 0.17±0.02 
CC 52.33±3.48 219.83±15.76# 535.00±87.81# 1.07±0.08# 0.28±0.05# 
SC 57.60±5.66 154.83±8.77* 426.00±46.81 0.62±0.05** 0.15±0.02* 
FB 55.17±4.77 147.67±11.58* 409.83±59.34 0.48±0.03** 0.13±0.02* 
CB 52.17±7.28 151.83±7.98* 494.17±79.35 0.52±0.06** 0.15±0.03* 
Data: Mean±SEM, # p <0.05, # p <0.001 when compared to normal control group; * p <0.05, ** p <0.001 when compared to cholesterol 
control group 
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normal control rats. This establishes the efficacy of 
the experimental protocol to induce hyperlipidemic 
condition. Lipid metabolism to great extent depends 
upon the formation and turnover of lipoproteins. 
Almost all lipids in the plasma are transported in the 
form of complexes with proteins; these proteins are 
termed as lipoproteins30. 
Both test drugs significantly, lowered the 
cholesterol level, triglyceride and VLDL cholesterol 
level in rats. The reversal effect was more pronounced 
in CB treated animals than FB treated animals in 
comparison to control group. The cholesterol-
lowering effect of the drugs might be due to inhibition 
of dietary cholesterol absorption or esterification. 
Since two enzymes are involved in these two 
processes viz. pancreatic cholesterol esterase31 and 
intestinal acyl Co-A-cholesterol acyltransferase 
enzyme (ACAT) 32, thus it could be suggested that the 
test drugs inhibit the activity of one or both of these 
enzymes. In both the test drugs ω-7 fatty acids were 
found which are responsible for lowering cholesterol 
level.  
The decrease in cholesterol may indicate increased 
oxidation of mobilized fatty acids of inhibition or 
lipolysis. CB, FB and atorvastatin produced a highly 
significant decrease in the triglyceride levels and 
VLDL level compared to the cholesterol-fed group. 
Reduction in cholesterol, triglycerides and VLDL 
level may probably be due to the presence of steroids, 
flavonoids and polyphenolic compounds in 
Bhallataka33. Flavonoids are a group of ubiquitously 
distributed plant polyphenols which exhibit a wide 
range of pharmacological effects. The inhibition of 
lipid peroxidation is due to the free radical scavenging 
property of flavonoids. They scavenge free radical by 
donating their hydrogen groups and prevent the 
initiation of a chain reaction. They also scavenge 
singlet O2, terminating peroxides by their low redox 
potential34. They also reduce lipid peroxidation by 
reducing the levels of malondialdehyde and 
conjugated dienes35. Both the drugs have the presence 
of steroids, tannins, phenolic compounds, flavonoids 
and amines. The plant steroids reduce the absorption 
of cholesterol and thus increase faecal excretion of 
cholesterol36. 
SGOT is a mitochondrial enzyme released from 
heart, liver, skeletal muscle and kidney. SGPT is a 
cytosolic enzyme primarily present in the liver37. 
Serum alkaline phosphatase is produced by many 
tissues, especially bone, liver, intestine and placenta 
and excreted in bile. Serum amino-transferase and 
alkaline phosphatase are elevated in most liver 
 
 
Fig. 1 — Photomicrographs of sections of aorta taken at 200x
magnification. a) Normal cytoarchitecture (control group) b) and
c) Increase in thickness of adventitia layer (CC) (d, e and f)
Normal cytoarchitecture (FB, CB and SC respectively) 
 
 
 
Fig. 2 — Photomicrographs of sections of heart taken at 200x 
magnification. a) Normal cytoarchitecture (control group) b) and
c) Moderate fatty degenerative changes and necrosis (CC) (d and 
e) Mild fatty changes (FB and CB) f) Moderate fatty degenerative
changes and necrosis (SC). 
INDIAN J NAT PROD RESOUR, JUNE 2018 
 
 
148
disorders. Highest elevations are found in conditions 
causing extensive hepatic necrosis such as severe 
acute viral hepatitis, toxic hepatitis or prolonged 
circulatory collapse38. Cholesterol-fed rats exhibited 
an insignificant increase in SGOT and a significant 
increase in alkaline phosphatase (p <0.001) level 
suggests the liver, heart and kidney damage in rats. 
Test drug non-significantly decreased the level of 
alkaline phosphatase while a significant decrease in 
SGOT which suggests the protective role of the test 
drug in high fat diet-induced hyperlipidemia in rats.  
A previous study showed that increased levels of 
total cholesterol, free cholesterol, phospholipids, 
triglycerides and free fatty acids and decreased levels 
of ester cholesterol in plasma, liver and kidney found 
in cancer-suffering animals were reverted back to near 
normal levels on treatment with the formulation  
of Bhallataka39. Further, it reduces the tissue  
and serum hyperlipidemia by the inhibition of 
intestinal cholesterol absorption coupled with 
peripheral disposal thus possessing anti-
artherosclerotic activity29. S. anacardium nut. extract 
oil fraction at a dose of 1 mg/100 g body weight 
significantly reduced serum cholesterol levels and 
increased HDL cholesterol levels in the rat fed with 
atherogenic diet40. In this context, a number of other 
plants have also been reported to have 
antihyperglycemic, antihyperlipidemic and insulin 
stimulatory effects41,42. 
 
Conclusion 
From the present study, it is concluded that fresh and 
cured Bhallataka Kshaudra prepared as per classical 
method have anti-hyperlipidaemic activity in 
cholesterol-fed albino rats. Cured Bhallataka Kshaudra 
has a more pronounced effect than fresh Bhallataka 
Kshaudra in lowering cholesterol and related parameters 
which may due to the presence of more amount of ω-7 
fatty acids, steroids, flavonoids and polyphenolic 
compounds in cured one as compared to fresh one. 
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